APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer’s Disease Risk in a Multiracial SampleKyu Choi, Gyungah Jun, Jonathan L. Haines et al.|Journal of Clinical Medicine|2019Cited by 76
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test dataMin Ju Kang, Young Chul Youn, SangYun Kim et al.|BMC Medical Informatics and Decision Making|2019Cited by 71
Facility-based and home-based multidomain interventions including cognitive training, exercise, diet, vascular risk management, and motivation for older adults: a randomized controlled feasibility trialSo Young Moon, Seong Hye Choi, Chang Hyung Hong et al.|Aging|2021Cited by 63
Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's diseaseKyung Won Park, Jae Woo Kim, Hyun Jin Yoon et al.|Psychiatry Research Neuroimaging|2012Cited by 48
Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related PhenotypesSang‐Hyuk Jung, Hong‐Hee Won, Hang‐Rai Kim et al.|JAMA Network Open|2022Cited by 47